Baxter International Inc.

Baxter International develops and provides healthcare products worldwide through four segments: Medical Products, Healthcare Systems, Pharmaceuticals, and Kidney Care. The company offers a range of products including IV solutions, infusion systems, surgical equipment, patient monitoring technologies, and more. Its products are used in hospitals, clinics, and patients homes. Baxter sells its products directly and through distributors, wholesalers, and specialty pharmacies globally. The company has agreements with Celerity Pharmaceutical and Miromatrix Medical to develop new products. It was founded in 1931 and is headquartered in Illinois.

Overview

Sector

Medical Instruments & Supplies

Target Price

0.0 USD

Current Price

30.6 USD

Potential

-100%

Strengths

Price to book ratio (2.25) is lower than the sector mean (3.86).

Weaknesses

With a depreciation Potential of -100.00%, based on our fundamental analysis, it suggests the stock may be overvalued.
Analysts expect revenues to decline in the coming year.
The company has high debt. Net Debt to EBITDA Ratio (7.27) is higher than the sector mean.
The company have lower returns than the sector in which it operates. ROIC (5.07%) is significantly lower than the sector mean (8.23%).
EV/EBIT (226.95) is significantly higher than the sector mean.

Key Financial Data

Indicator	Value
PER	100.0
EV/EBITDA	17.3
Price/Free Cash Flow'	28.0
ROIC	5.1%
Net Debt/EBITDA	7.3